Tracked deals
3
3 tracked deals across 2021-2026.
Blue Bell, Pennsylvania, United States
For 25+ years, Signant Health has pioneered solutions and methodologies that propel clinical research programs toward regulatory success, combining deep scientific expertise with comprehensive eClinical solutions to capture reliable evidence while making trials more manageable for sites and more meaningful for patients.
Tracked deals
3
3 tracked deals across 2021-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
2 buyout · 1 divestiture
Last 3 years
Supporting Data
Signant Health announced its acquisition of Ametris (formerly ActiGraph), combining eCOA solutions with wearable-derived digital outcome measures. The combined platform integrates patient-reported outcomes with continuous sensor data to help sponsors simplify multimodal clinical studies and strengthen regulatory evidence packages.
Signant Health has acquired DSG, a provider of electronic data capture (EDC) and direct data capture (DDC) technology, to extend its unified eClinical solution suite for traditional, hybrid, and decentralized clinical trials. The acquisition adds DSG's site-friendly EDC/DDC capabilities and operational efficiencies to Signant's software, analytics, and logistics offerings, strengthening Signant's end-to-end digital trial platform.
Signant Health has acquired VirTrial, a Scottsdale-based provider of telemedicine and virtual site monitoring software for clinical trials, from private equity owner Kinderhook Industries. The acquisition expands Signant Health's digital clinical-trial capabilities by adding VirTrial's virtual-visit, secure video/chat, connected device and virtual site monitoring solutions to Signant's evidence-generation technology stack.
Turn tracked acquisition activity into an outreach-ready buyer list.